Welcome to our dedicated page for National Health Investors news (Ticker: NHI), a resource for investors and traders seeking the latest updates and insights on National Health Investors stock.
National Health Investors, Inc. (NYSE: NHI) is a self-managed real estate investment trust focused on senior housing and medical facility investments, and its news flow reflects this specialized role in healthcare real estate finance. Incorporated in 1991, the company concentrates on sale-leasebacks, joint ventures, senior housing operating partnerships, and mortgage and mezzanine financing for need-driven and discretionary senior housing and medical properties.
The NHI news stream frequently covers investment activity and pipeline updates, including acquisitions of assisted living and memory care communities, independent living facilities, and retirement communities, as well as mortgage loans secured by senior housing properties. Press releases often detail transaction structures, such as triple-net master leases, SHOP segment acquisitions, and loans with purchase options, along with initial yields or interest rates and lease terms.
Investors can also expect earnings announcements and guidance updates, where NHI reports net income attributable to common stockholders, NAREIT FFO, normalized FFO, and normalized FAD, and provides annual guidance ranges with underlying assumptions about investment volume, SHOP performance, rent collections, and capital deployment. These releases may describe changes in rental income, resident fees and services, interest income, and credit loss reserves, as well as updates on at-the-market equity programs and leverage metrics.
Additional NHI news items include dividend declarations, investor presentations and webcasts, pricing and completion of senior notes offerings, and selected tenant and lease developments, such as transitions of properties into the SHOP segment or notices of non-compliance under master leases. For readers tracking NHI stock and the senior housing REIT space, this page offers a centralized view of the company’s operational, financing, and portfolio developments over time.
National Health Investors (NYSE:NHI) announced the preliminary results of its 2025 Annual Meeting of Stockholders, where shareholders elected all four of the company's director nominees: Robert G. Adams, Robert W. Chapin, Jr., James R. Jobe, and Candice W. Todd. The company acknowledged the constructive dialogue with stockholders and highlighted recent corporate governance improvements, including the declassification of its Board. NHI expressed confidence in its strategy to generate superior total shareholder return while recognizing the need for continued improvements. The company has retained Hogan Lovells US LLP as legal counsel and Sodali & Co. as proxy solicitor. Final voting results will be filed with the SEC on Form 8-K.
National Health Investors (NYSE:NHI) has declared its second quarter dividend for 2025. The company will distribute a dividend of $0.90 per common share to shareholders. The dividend will be paid on August 1, 2025, to stockholders who are on record as of June 30, 2025.
National Health Investors (NYSE:NHI) has announced a change in the timing of its first quarter 2025 earnings conference call and webcast. The event has been rescheduled from 11:00 a.m. to 10:00 a.m. Eastern Time on Tuesday, May 6, 2025. The company will release its earnings report after market close on Monday, May 5, 2025.
Investors can participate in the interactive teleconference by calling (888) 506-0062 with access code 111859. A live broadcast will be available online at www.nhireit.com and through the company's webcasting platform, with an online replay remaining accessible for one year after the event.
National Health Investors (NYSE:NHI) has mailed a letter to stockholders ahead of its May 21, 2025 Annual Meeting, urging them to vote 'FOR' four Board nominees on the WHITE proxy card. The letter highlights NHI's superior shareholder returns, with the company outperforming key REIT indices over 1-year, 3-year, and 5-year periods through December 31, 2024.
The company has significantly refreshed its Board since May 2020, adding six new members and increasing Board diversity from 0% to 37.5%. Notable achievements include reducing average tenure from 21 to 7 years and appointing new committee chairs. A Special Committee of Non-Interested Directors has been formed to oversee lease negotiations with National Healthcare (NHC), which represents 14% of NHI's 2024 NOI.
The letter addresses Land & Buildings' (L&B) proxy contest, which owns 1.3% of shares and nominated candidates to replace two board members. NHI's Board argues that L&B's candidates do not add value to the current Board's skill sets and that L&B has not proposed substantive ideas for improvement.
National Health Investors (NYSE:NHI) has scheduled its first quarter 2025 earnings release and conference call. The company will release its financial results for Q1 2025 (ended March 31) after market close on Monday, May 5, 2025.
A conference call to discuss the results will be held the following day, Tuesday, May 6, 2025, at 11:00 a.m. Eastern Time. Investors can participate in the interactive teleconference by calling (888) 506-0062 with access code 111859. The call will also be broadcast live online at www.nhireit.com, with a replay available for one year.
Land & Buildings Investment Management, a significant stockholder of National Health Investors (NHI), has filed definitive proxy materials and sent a letter to stockholders advocating for boardroom change at the upcoming 2025 Annual Meeting on May 21, 2025.
The activist investor is nominating two independent candidates - Adam Troso and Jim Hoffmann - citing concerns over NHI's corporate governance and conflicts of interest, particularly regarding ongoing lease renewal negotiations with major tenant National Healthcare Corp (NHC).
Key issues highlighted include:
- NHI's significant underperformance: -61% vs peers over 5 years, -19% over 3 years, and -27% over 1 year
- Potential 60% upside in NHC lease renewal, representing approximately $0.55/share or 12% FFO/share increase
- Forecast of $1 billion in senior housing acquisitions over next 12-24 months, potentially increasing FFO/share by 10%
- Board conflicts including multiple directors' significant stock ownership in tenant NHC
National Health Investors (NYSE:NHI) has filed definitive proxy materials for its Annual Meeting scheduled for May 21, 2025. The company is urging stockholders to vote 'FOR' four board nominees amid a challenge from activist hedge fund Land & Buildings (L&B), which owns 1.3% of shares.
NHI reported strong performance in 2024 with a 30.6% total shareholder return (TSR), outperforming the Nareit Healthcare REIT Index. The company achieved $235 million in investments at an 8.6% average yield and has already closed $136.4 million in investments in 2025.
Key highlights include: board refreshment with four new members in four years, commitment to remove classified board structure, creation of a Special Committee for NHC lease negotiations, and improved financial metrics including a 32% increase in Senior Housing Operating Portfolio NOI. The company raised approximately $278.4 million in equity proceeds, with $68.9 million remaining available as of March 2025.